If I told you that light — specific wavelengths of red and near-infrared light, delivered at the right dose — can influence how your cells produce energy and how injured tissue recovers, you would be entirely within your rights to raise an eyebrow. I did exactly that, years ago. It sounded like the kind of claim that belongs in a magazine advert next to copper bracelets and detox patches.
Then I read the underlying research. Then I trained in it properly. And today, laser therapy is one of the most-used tools in my clinic — not because it's impressive to demonstrate, but because I watch what it does to my patients' recovery timelines.
So let me explain it the way I wish someone had explained it to me: mechanism first, evidence second, and — most importantly — limitations stated plainly. Because the fastest way to discredit a genuinely useful technology is to oversell it, and this field has suffered badly from people doing exactly that.
What Photobiomodulation Actually Is
The proper name for the field is photobiomodulation (PBM) — previously called low-level laser therapy. The principle is that light of particular wavelengths, typically in the red (around 600–700 nm) and near-infrared (around 780–1100 nm) ranges, penetrates tissue and is absorbed by specific molecules inside your cells, producing biological effects. It's non-thermal at therapeutic doses: we're not cooking tissue, we're signalling to it.
The key absorber — the best-characterised one — is cytochrome c oxidase, an enzyme sitting in the membrane of your mitochondria. Mitochondria are your cells' power stations: they take oxygen and fuel and produce ATP, the energy currency that every repair process depends on. Cytochrome c oxidase is the final enzyme in that production line.
Here's the mechanism in plain terms. Under stress — injury, inflammation, poor perfusion — nitric oxide can bind to cytochrome c oxidase and inhibit it, throttling the cell's energy production at exactly the moment the cell most needs energy to repair. Red and near-infrared light appear to displace that inhibitory nitric oxide, releasing the brake. ATP production rises. Brief, controlled increases in reactive oxygen species act as signalling molecules, switching on gene expression pathways involved in repair, antioxidant defence and inflammation control (Hamblin, 2017; de Freitas & Hamblin, 2016).
Downstream, three effects matter clinically: modulation of inflammation (shifting the local environment from prolonged inflammatory signalling toward resolution), improved local circulation, and enhanced cellular capacity for repair and proliferation. This is not fringe speculation — the cellular mechanisms have been mapped in detail across two decades of laboratory work in peer-reviewed journals.
What the Clinical Evidence Supports
Mechanism is necessary but not sufficient — plenty of biologically plausible ideas fail in real patients. So what do the human trials show?
Musculoskeletal pain. A systematic review and meta-analysis examining laser therapy across musculoskeletal disorders found significant reductions in pain compared to placebo when appropriate parameters were used (Clijsen et al., 2017). Condition-specific reviews have supported use in neck pain and certain tendinopathies, and PBM appears in some clinical guidelines as an option within multimodal care.
Tissue repair and wound healing. This is where the evidence base is oldest, arising from wound-healing research, and where the mechanism argument is most direct: support cellular energy production during the repair phase and repair proceeds better.
Muscle recovery and performance. A systematic review with meta-analysis found that phototherapy applied around exercise reduced markers of muscle damage and improved recovery metrics between sessions (Leal-Junior et al., 2015). This is why PBM has become common in elite sport recovery protocols.
Oral mucositis — severe mouth ulceration in cancer patients undergoing chemotherapy and radiotherapy — deserves special mention as the field's strongest evidence. PBM is recommended in international supportive-care guidelines for prevention in specific patient groups (Zadik et al., 2019). I mention it because it's the clearest proof that this is real medicine with real regulatory acceptance, not wellness theatre.
Now the Honest Part: Why Results Vary So Much
If you search the literature yourself, you'll find inconsistent results — some trials positive, some null. Rather than hide that, let me explain it, because the explanation is the most important thing in this article.
Dose is everything, and it's easy to get wrong. PBM follows a biphasic dose-response — often called the Arndt-Schulz curve. Too little energy produces no effect. The right dose produces benefit. Too much produces inhibition — you can overshoot into a negative result (Huang et al., 2009). This is unlike most therapies people are familiar with, where more feels safer. Many null trials in the literature simply used inappropriate parameters.
Wavelength must match the target depth. Red light is absorbed more superficially; near-infrared penetrates deeper. Treating a deep hip structure with parameters designed for superficial tissue is a predictable failure, and reviewers have repeatedly identified poor parameter reporting as a core problem in the literature.
Power and delivery matter. There is a genuine, substantial difference between a low-powered consumer device and professional-grade equipment able to deliver adequate energy to deep tissue in a clinically practical time. This is one area where the equipment genuinely matters — which is why I invested in an MLS® laser system rather than the cheapest option available.
Technique matters. Contact versus non-contact application, treating over skin versus through clothing, the area covered, the treatment frequency — all influence delivered dose.
The summary I give patients: PBM is a pharmacological-style intervention delivered as light. Nobody would judge a medication by trials that used random doses of unspecified compounds — and much of the negative PBM literature is exactly that.
How I Actually Use It — and What I Tell Patients
Here's the framing I use with every patient before their first laser session, because expectation management is part of good treatment.
Laser is an accelerator, not a cure. It creates favourable biological conditions — less pain, less inflammation, better cellular energy at the repair site. What it categorically cannot do is strengthen a weak muscle, restore a lost movement pattern, retrain a proprioceptive deficit, or correct the biomechanics that caused the overload. Those require your active participation, and they are what produce lasting change. If I gave you twelve laser sessions and nothing else, you would probably feel better for a while and then relapse — because the cause would be untouched.
Its main clinical value is the window it opens. An inflamed, painful joint or tendon won't tolerate the loading that rehabilitation requires. Laser reliably reduces that barrier, and a patient who can move sooner and load earlier recovers faster and more completely. In that sense the technology serves the rehabilitation — never the reverse.
Where it earns its place in my programmes: the acute inflammatory phase of injuries; irritable tendinopathies where load must be introduced but the tissue is too reactive to accept it; post-surgical recovery, supporting tissue healing and managing pain; chronic joint pain, as part of the calm-down phase before strengthening; and around demanding rehabilitation sessions to support recovery between them.
Safety and honesty. PBM has an excellent safety profile at therapeutic doses — the main precaution is eye protection, which is non-negotiable during treatment, plus standard caution over malignancy, pregnancy, and thyroid regions. It is not appropriate for everyone, and I say so when it isn't indicated rather than applying it universally because the machine exists.
Where Laser Sits Among the Other Technologies
Patients frequently ask why my clinic uses several different technologies rather than one, and whether that's genuine or just equipment collecting. Fair question — here's the reasoning, because each tool answers a different problem.
Laser (PBM) works at the cellular level: energy production, inflammation modulation, tissue repair support. Its natural home is the biology of healing.
Electrotherapy currents work primarily at the neurological level — modulating pain signalling, and in some applications recruiting muscle that pain has switched off. Different mechanism, different job. When a quadriceps has gone quiet after knee injury or surgery, that's a neuromuscular problem, not a cellular energy one.
Therapeutic ultrasound delivers mechanical energy into tissue, with its own indications — and, I'd add honestly, a mixed evidence base that's weaker than PBM's in several applications. I use it selectively rather than reflexively.
Thermography isn't treatment at all — it's measurement, mapping surface temperature patterns that can reflect inflammation and circulation. Its value is in seeing what's happening and tracking whether it's changing.
Manual therapy and exercise remain the backbone. Everything above serves them.
The reason for the panel is simple: injuries present with different limiting factors. One patient is limited by inflammation, another by neuromuscular inhibition, another by tissue stiffness, another by fear and deconditioning. Matching the tool to the actual limiting factor — rather than applying the same protocol to everyone because it's what the clinic owns — is what separates individualised treatment from a production line. And when none of the technology addresses the limiting factor, the honest answer is to put it down and coach the exercise instead.
The Wider "Light" Conversation — Separating Signal From Noise
Because red light panels have become a wellness craze, patients often ask me about home devices and adjacent claims. My honest positions:
Home panels are not equivalent to clinical equipment for deep-tissue therapeutic dosing — the power densities are typically far lower, and marketing rarely reports parameters meaningfully. That doesn't make them worthless; it makes them different, best thought of as low-dose maintenance rather than treatment.
Claims well beyond the evidence are everywhere — fat loss, hair regrowth, cognitive enhancement, "detoxification". Some of these have preliminary research (transcranial PBM is a genuinely interesting research area), most are marketing running far ahead of data. I'd rather be the clinician who says "the evidence for that isn't there yet" than the one who sells hope by the session.
And a point I make often: the most powerful light intervention available to you costs nothing and involves stepping outside in the morning. Daylight anchors the circadian system that governs your sleep, hormonal rhythms and repair windows. If someone is investing in a red light panel while chronically avoiding morning daylight, they have their priorities inverted.
A Short History, and Why the Name Changed
A brief detour that explains a lot about the field's reputation.
The observation that light affects living tissue goes back further than most people assume. In 1903, Niels Finsen received the Nobel Prize in Medicine for treating skin tuberculosis with concentrated light — the first formal recognition that light could be therapy rather than merely illumination. The modern era began in the late 1960s, when the Hungarian researcher Endre Mester, testing whether laser light caused cancer in rodents, found instead that shaved fur regrew faster and wounds healed more quickly in treated animals. He had discovered the effect while looking for the opposite.
For decades afterwards the field was called "low-level laser therapy", and that name did it real damage. "Low-level" sounded weak and unserious; "laser" attracted both mystique and scepticism; and because the mechanism wasn't well understood, the space filled with practitioners making claims far beyond the data. Good science and poor marketing grew side by side, and the marketing was louder.
The rebranding to photobiomodulation in the mid-2010s was a deliberate scientific correction. The new name is more accurate on every count: the effect isn't exclusive to lasers (LEDs produce it too), "low-level" was misleading given that dose is what matters, and modulation captures the actual biology — the light doesn't force a single outcome, it nudges cellular processes toward normal function, which is why the same treatment can calm an over-inflamed tissue and support an under-performing one.
I explain this history to patients because it clarifies something important: the scepticism this field attracts is earned, but it's earned by its salespeople rather than its science. The underlying mechanism is legitimate, published and increasingly well characterised. What's needed is honest application and honest claims — and that's a standard any clinic offering it should be held to, including mine.
Frequently Asked Questions
Does it hurt? No. Therapeutic PBM is painless; most patients feel a mild, pleasant warmth from higher-power systems, or nothing at all. Sessions are typically short — several minutes per region.
How many sessions before I notice something? Many patients notice a difference in pain within the first two or three sessions, though the tissue-level effects accumulate over a course. If several sessions produce nothing at all, that's information — either the parameters need adjusting or PBM isn't the right tool for that problem, and I'll say so.
Is it the same as a heat lamp or infrared sauna? No. Those work primarily through heat. Therapeutic PBM is non-thermal and operates through photochemical absorption at specific wavelengths — a different mechanism entirely.
Can it be used with medication or after surgery? Generally yes, and it's frequently valuable post-surgically — but always as part of an assessed plan, with your surgical team's timeline respected.
Is it a substitute for exercise-based rehabilitation? No. And I'd be cautious with any clinic that suggests otherwise — that's the clearest signal that a genuinely useful technology is being oversold.
How to Judge a Clinic That Offers Laser Therapy
Since you may encounter this technology elsewhere, here's how I'd evaluate a provider — including me.
Ask what parameters they use, and why. A clinician who can tell you the wavelength, the power, the energy dose and why those suit your specific tissue depth is applying medicine. One who says "we just do ten minutes on everything" is applying a routine. Given the biphasic dose-response (Huang et al., 2009), that distinction is the difference between benefit and nothing.
Ask what else is in the plan. If laser is the entire treatment, be sceptical. Every credible application of PBM in musculoskeletal care sits inside a broader rehabilitation programme.
Notice how it's sold. "This will accelerate your healing and reduce your pain so we can start loading sooner" is an honest claim. "This regenerates cartilage / cures arthritis / eliminates the need for surgery" is not, and no current evidence supports it.
Ask about a review point. Any reasonable course of treatment should have a moment where effectiveness is assessed and the plan is revised — including the possibility of stopping. Open-ended packages of sessions sold up front, with no review criteria, serve the clinic's cash flow more than the patient's recovery.
I hold my own practice to these standards, and I'd rather patients arrive equipped to ask them than take my word for it. Technology that genuinely works survives scrutiny comfortably.
A Final Word
The way I frame it to my patients is this: rehabilitation is a journey your body has to make regardless. Tools like MLS laser therapy don't carry you — they improve the road conditions. Less pain along the way, better biology at the repair site, and usually a faster arrival at the same destination.
That's a modest claim compared to what some clinics promise. It's also, in my experience and in the literature, an accurate one — and accuracy is what patients deserve when someone points expensive equipment at their body and tells them it will help.
References
- Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017;4(3):337–361.
- de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE Journal of Selected Topics in Quantum Electronics. 2016;22(3):7000417.
- Clijsen R, Brunner A, Barbero M, et al. Effects of low-level laser therapy on pain in patients with musculoskeletal disorders: a systematic review and meta-analysis. European Journal of Physical and Rehabilitation Medicine. 2017;53(4):603–610.
- Leal-Junior EC, Vanin AA, Miranda EF, et al. Effect of phototherapy on exercise performance and markers of exercise recovery: a systematic review with meta-analysis. Lasers in Medical Science. 2015;30(2):925–939.
- Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose-Response. 2009;7(4):358–383.
- Zadik Y, Arany PR, Fregnani ER, et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer. 2019;27(10):3969–3983.